 |
|
|
| |
Outcomes in Those Who Discontinued Injectable
Cabotegravir/Rilpivirine and Resumed Oral Antiretroviral Therapy
|
| |
| |
CROI 2025 SF March 9-12
Tali Faggiano,1 Jeffrey Yin,1 Nimish Patel,2 Afsana Karim,1 Laura Bamford,1 Lucas Hill1
1Univerisity of California San Diego Owen Clinic, San Diego, USA 2University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, USA
|
| |
|
|
|
|
|
